Cargando…
Effect of pretreatment with a P2Y(12) inhibitor in patients with non-ST-elevation acute coronary syndrome: a systematic review and network meta-analysis
BACKGROUND: This study aimed to systematically evaluate the effects of different types and doses of pretreatment with P2Y(12) inhibitors in patients with non-ST-elevation acute coronary syndrome (NSTE-ACS) undergoing percutaneous coronary intervention (PCI). METHODS: Electronic databases were search...
Autores principales: | Li, Yachao, Lei, Mengjie, Zhao, Zhigang, Yang, Yanli, An, Lei, Wang, Jingyao, Sun, Xue, Li, Cairong, Xue, Zengming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394276/ https://www.ncbi.nlm.nih.gov/pubmed/37539086 http://dx.doi.org/10.3389/fcvm.2023.1191777 |
Ejemplares similares
-
Effectiveness of dual antiplatelet de-escalation therapy on the prognosis of patients with ST segment elevation myocardial infarction undergoing percutaneous coronary intervention
por: Zhao, Zhigang, et al.
Publicado: (2023) -
A novel de-escalation antiplatelet therapy for patients with acute coronary syndrome undergoing percutaneous coronary intervention
por: Li, Yachao, et al.
Publicado: (2023) -
Impact of infection in patients with non-ST elevation acute coronary syndrome undergoing percutaneous coronary intervention: insight from a multicentre observational cohort from China
por: Chen, Peng-Yuan, et al.
Publicado: (2020) -
Elevated Serum Levels of Soluble ST2 Are Associated With Plaque Vulnerability in Patients With Non-ST-Elevation Acute Coronary Syndrome
por: Luo, Guqing, et al.
Publicado: (2021) -
Associations of Lipoprotein(a) With Coronary Atherosclerotic Burden and All-Cause Mortality in Patients With ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention
por: Xue, Yuzhou, et al.
Publicado: (2021)